| Pharmaceutical active ingredients: |
| Erythromycin |
| Available forms, composition and doses of Taimoxin-F: |
| N / A |
| Taimoxin-F medical category: |
| Human:Acne treatment preparationsAntibacterialsErythromycinsEye anti-infectives and antisepticsMacrolidesTopical antibiotics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01FA01 - ErythromycinS01AA17 - Erythromycin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Taeniatol | Dichlorophene | Unidentified Pharmaceutical Company |
| Tafidex | Clofenotane | Unidentified Pharmaceutical Company |
| Tagathen | Chloropyrilene | Unidentified Pharmaceutical Company |
| Tai-Ace K | Aluminum Potassium Sulfate | Unidentified Pharmaceutical Company |
| Taifen | Propineb | Unidentified Pharmaceutical Company |
| Taizer | Meclizine | Unidentified Pharmaceutical Company |
| Tajmalin | Ajmaline | Unidentified Pharmaceutical Company |
| Takamina | Epinephrine | Unidentified Pharmaceutical Company |
| Takamine | Epinephrine | Unidentified Pharmaceutical Company |
| Takanarumin | Allopurinol | Unidentified Pharmaceutical Company |